Over-the-counter drug · NDA
Claritin Reditabs (loratadine) NDC 11523-7202
Loratadine 5 mg/1 · Tablet, Orally disintegrating · Oral · Bayer HealthCare LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 11523-7202-1 | 11523720201 | 3 BLISTER PACK in 1 CARTON (11523-7202-1) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Dec 12, 2006 | |
| 11523-7202-3 | 11523720203 | 1 BLISTER PACK in 1 CARTON (11523-7202-3) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Dec 12, 2006 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Claritin ReditabsSuffix: Reditabs
- Generic name (nonproprietary)
- loratadine
- Active ingredients
- Loratadine — 5 mg/1
- Dosage form
- Tablet, Orally disintegrating
- Route
- Oral
- Labeler
- Bayer HealthCare LLC
- Product type
- Over-the-counter drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021993
- Marketing start
- Listing expires
- Identifiers
- Product ID 11523-7202_45371bc6-b83d-a96d-e063-6294a90a7c40SPL ID 45371bc6-b83d-a96d-e063-6294a90a7c40SPL set ID 7dc04b48-f053-4e4b-a493-9e8286d2a791RxCUI 672558, 904026UNII 7AJO3BO7QN
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N411523720201followed by a unit qualifier and the quantityPackage 11523-7202-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
Excerpt only. Read the full label for complete information.